Literature DB >> 19837936

Six new mutations of the thyroglobulin gene discovered in taiwanese children presenting with thyroid dyshormonogenesis.

Dau-Ming Niu1, Ju-Hui Hsu, Kah-Wai Chong, Cheng-Hung Huang, Yung-Hsiu Lu, Chuan-Hong Kao, Hsiao-Chi Yu, Ming-Yu Lo, Tjin-Shing Jap.   

Abstract

BACKGROUND: Thyroglobulin (TG) defect is a rare cause of congenital hypothyroidism. Although only 44 mutations of the human TG gene have been identified, we have suspected a TG defect in 38% of Taiwan Chinese children/adolescents presenting with moderate or severe thyroidal dyshormonogenesis. STUDY
OBJECTIVE: The aim of the study is to report the discovery of new TG gene mutations and associated clinical manifestations of the defective TG protein. PATIENTS AND
RESULTS: In seven patients from six families, we detected six new TG gene mutations, including c.1348delT, p.R432X (c.1351C>T), g.IVS3 + 2T>G, c.1712delT, p.Q1765X (c.5350C>T), and c.6047delA. The c.1348delT and p.R432X mutations were the most common, detected in 33 and 25%, respectively, of alleles studied. Haplotype analysis suggested that the c.1348delT and g.IVS3 + 2T>G mutations are due to founder effects, whereas p.R432X is probably due to independently recurrent de novo mutations. mRNA transcript of the g.IVS3 + 2T>G mutant, detected in whole blood by reverse transcription-nested PCR, showed skipping of exon 3 (98-bp deletion) and a frameshift, with a terminal signal after 17 altered amino acid residues.
CONCLUSIONS: TG defects have an important role in severe thyroidal dyshormonogenesis (pretreatment, or after a 3-wk T(4) withdrawal, plasma T(4) < or = 30 nmol/liter) in Taiwanese. Its genetic characteristics are markedly different from those described in other populations presenting with mutations of the TG gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837936     DOI: 10.1210/jc.2009-0646

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Clinical, biochemical, and molecular findings in Argentinean patients with goitrous congenital hypothyroidism.

Authors:  Ana Chiesa; Carina M Rivolta; Héctor M Targovnik; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

3.  The genetic characteristics of congenital hypothyroidism in China by comprehensive screening of 21 candidate genes.

Authors:  Feng Sun; Jun-Xiu Zhang; Chang-Yi Yang; Guan-Qi Gao; Wen-Bin Zhu; Bing Han; Le-Le Zhang; Yue-Yue Wan; Xiao-Ping Ye; Yu-Ru Ma; Man-Man Zhang; Liu Yang; Qian-Yue Zhang; Wei Liu; Cui-Cui Guo; Gang Chen; Shuang-Xia Zhao; Ke-Yi Song; Huai-Dong Song
Journal:  Eur J Endocrinol       Date:  2018-04-12       Impact factor: 6.664

4.  Congenital Primary Hypothyroidism with the Homozygous Nonsense Mutation P.K1374* in the Thyroglobulin Gene and a Normal-sized Thyroid Gland on Levothyroxine Replacement.

Authors:  Tetsuya Mizokami; Shuji Fukata; Takahiko Kogai; Akira Hishinuma; Katsuhiko Hamada; Tetsushi Maruta; Kiichiro Higashi; Junichi Tajiri
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

5.  Novel truncating thyroglobulin gene mutations associated with congenital hypothyroidism.

Authors:  Hakan Cangul; Kristien Boelaert; Murat Dogan; Yaman Saglam; Michaela Kendall; Timothy G Barrett; Eamonn R Maher
Journal:  Endocrine       Date:  2013-08-15       Impact factor: 3.633

6.  High Diagnostic Yield of Targeted Next-Generation Sequencing in a Cohort of Patients With Congenital Hypothyroidism Due to Dyshormonogenesis.

Authors:  Athanasia Stoupa; Ghada Al Hage Chehade; Rim Chaabane; Dulanjalee Kariyawasam; Gabor Szinnai; Sylvain Hanein; Christine Bole-Feysot; Cécile Fourrage; Patrick Nitschke; Caroline Thalassinos; Graziella Pinto; Mouna Mnif; Sabine Baron; Marc De Kerdanet; Rachel Reynaud; Pascal Barat; Mongia Hachicha; Neila Belguith; Michel Polak; Aurore Carré
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-22       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.